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Background: Phase contrast cardiovascular magnetic resonance (PC CMR) has emerged as a clinical tool for blood
flow quantification but its use in the foetus has been hampered by the need for gating with the foetal heart beat. The
previously described metric optimized gating (MOG) technique has been successfully used to measure foetal blood
flow in late gestation foetuses on a 1.5 T CMR magnet. However, there is increasing interest in performing foetal
cardiac imaging using 3.0 T CMR. We describe our pilot investigation of foetal blood flow measured using 3.0 T CMR.
Methods: Foetal blood flows were quantified in 5 subjects at late gestational age (35–38 weeks). Three were normal
pregnancies and two were pregnancies with ventricular size discrepancy. Data were obtained at 1.5 T and 3.0 T using a
previously described PC CMR protocol. After reconstruction using MOG, blood flow was quantified independently by
two observers. Intra- and inter-observer reproducibility of flow measurements at the two field strengths was assessed
by Pearson correlation coefficient (R2), linear regression and Bland Altman analysis.
Results: PC CMR flow measurements were obtained in 36 of 40 target vessels. Strong intra-observer agreement was
obtained between measurements at each field strength (R2 = 0.78, slope = 0.83 ± 0.11), with a mean bias of −1 ml/min/
kg and 95% confidence limits of ±71 ml/min/kg. Inter-observer agreement was similarly high for measurements at both
1.5 T (R2 = 0.86, slope = 0.95 ± 0.13, bias = 6 ± 52 ml/min/kg) and 3.0 T (R2 = 0.88, slope = 0.94 ± 0.13, bias = 4 ± 47 ml/
min/kg). Across all PC CMR measurements, SNR per pixel was expectedly higher at 3.0 T relative to 1.5 T (165 ± 50%).
The relative differences in flow measurements between observers were low (range: 4–16%) except for pulmonary blood
flow which showed much higher variability at 1.5 T (34%) versus that at 3.0 T (11%). This was attributed to the poorly
visualized, small pulmonary vessels at 1.5 T, which made delineation inconsistent between observers.
Conclusions: This is the first pilot study to measure foetal blood flow using PC CMR at 3.0 T. The flow data obtained
were in good correlation with those measured at 1.5 T, both within and between observers. With increased SNR at
3.0 T, smaller pulmonary vessels were better visualized which improved inter-observer agreement of associated flows.Background
Ultrasound is an essential tool for the antenatal diagno-
sis of congenital heart disease, providing both anatom-
ical and hemodynamic information at high temporal
resolution. However, quantification of blood flow, a key
hemodynamic parameter, is technically difficult by ultra-
sound. Inaccuracies arise from problems obtaining an
appropriate angle of insonation, difficulty in measuring* Correspondence: bevtsai@gmail.com
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article, unless otherwise stated.vessel area, and assumptions regarding the flow profile
across the vessel lumen [1,2].
In recent years phase contrast cardiovascular magnetic
resonance (PC CMR) has gained importance as a clinical
tool for blood flow quantification in postnatal patients
with cardiovascular disease [3] and does not have the
same limitations as ultrasonography. Cardiovascular mag-
netic resonance (CMR) is a widely available and safe tech-
nique for imaging the foetus. However, it is hampered by
the inability to accurately gate with the foetal heart beat
resulting in inadequate spatial and temporal resolution.
Our group has described a PC CMR technique withCentral. This is an Open Access article distributed under the terms of the
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Figure 1 Comparison of foetal flows measured at 3.0T versus 1.5T
using PC CMR with MOG. (a) Comparison of foetal flows measured
at 3.0 T versus 1.5 T using PC CMR with metric optimized gating.
Symbols = vessel type (see legend); Solid red line = linear regression;
Dashed lines = 95% confidence limits (b) Bland-Altman analysis of data
from (a). Solid red line =mean; Dashed = 95% confidence limits.
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foetal subjects [4,5], thus negating the need for ECG gat-
ing. This new technique has provided useful and novel in-
formation about blood flow in normal foetuses and those
with left sided heart lesions [6]. However, the original
technique and all hemodynamic flow data were obtained
using a field strength of 1.5 T.
There is growing interest in utilizing 3.0 T systems for
foetal imaging because signal to noise ratio (SNR) is im-
proved, which can then be used to reduce scan time or
obtain better spatial resolution. A recent qualitative
comparison of foetal anatomical imaging at 1.5 T and
3.0 T supports this expectation [7]. Here we present a
preliminary comparison of PC CMR blood flow meas-
urement in the foetus at 1.5 T and 3.0 T, using MOG.
Methods
All studies were approved by Toronto Hospital for Sick
Children Research Ethics Board.
Foetal flow data were obtained from five subjects
with gestational ages ranging from 35–38 weeks. The
mothers were recruited following their 20 weeks anom-
aly ultrasound examination. In two cases, mild ventricu-
lar disproportion (right ventricle larger than left) was
present, but resolved postnatally. The remaining three
foetuses were structurally normal. None of these infants
required surgery.
The CMR examinations were performed at 1.5 T and
3.0 T using Magnetom Avanto and Trio systems, re-
spectively (Siemens Healthcare – Erlangen, Germany).
The women were positioned in a lateral decubitus pos-
ition for the scans, which was well tolerated. Data were
acquired using surface coils (6 channel body matrix) in
conjunction with elements from the spine array.
Four out of the five subjects were scanned on both
scanners within the same day. For logistics reason, one
patient had her second scan a week later. To avoid pro-
cedural bias, scanner order was alternated between sub-
jects, and flow values were normalized by foetal body
mass to account for differences in maturation.
Each CMR scan took up to a maximum of 60 minutes
and was guided by the patient’s comfort level. Demographic
data was collected and anonymized. The foetal heart rate
was measured for 5 minutes using a cardiotocography
(CTG) device (Corometrics, GE Healthcare – Fairfield, CT,
USA) prior to CMR. The imaging protocol consisted of
localizers in three orthogonal planes followed by a steady
state free precession (SSFP) breath hold 3-dimensional ac-
quisition of the whole foetus to estimate foetal weight, as
described previously [8]. For prescription of the PC CMR
scans, 3-plane static SSFP anatomical images were acquired
through the foetal thorax (slice thickness 4 mm, slice gap
0.4 mm, repetition time 2.6 ms, echo time 1.14 ms, field of
view 350 × 231 mm, matrix size 320 × 211 × 170, 1 signalaverage, Grappa acceleration factor 2). The PC CMR scan
parameters were as follows: slice thickness 5 mm, echo time
2.92 ms, field of view 240 × 240 mm, matrix size 192 × 192,
33% phase oversampling, 1 signal average, no parallel im-
aging, 4 views per segment, temporal resolution 51.5 ms, 10
cardiac phases.
The following vessels were interrogated, equating to a
maximum of 8 flow measurements per foetus: main
pulmonary artery (MPA) (Additional files 1 and 2), branch
pulmonary arteries (LPA & RPA) (Additional files 3 and 4),
superior vena cava (SVC), arterial duct (AD), ascending
aorta (AAo) (Additional files 5 and 6) and descending aorta
at the diaphragm (DAo) using the anatomical images to
plan the prescriptions as in post-natal PC CMR. The intra-
abdominal portion of the umbilical vein (UV) proximal to
the left portal branches was targeted to avoid complex flow
behaviour. The velocity encoding range was tailored for the
individual vessels with 150 cm/s for the MPA, AAo, AD,
and DAo, 100 cm/s for the RPA, LPA and SVC and
50 cm/s for the UV.
Table 1 Diagnosis, biometric data, and measured flows
Flow (mL/min/kg)
Diagnosis B0 (T) GA (wk) EFW (kg) MPA AAO SVC AD DAO PBF UV
RV/LV 1.5 36 3.20 181 96 153 248 230 106 179
Disproportion 3.0 35 2.87 259 106 133 227 182 82 151
RV/LV 1.5 38 3.25 373 101 143 306 271 60 116
Disproportion 3.0 38 3.24 327 89 191 281 223 88 126
Normal 1.5 37 3.74 218 157 104 191 219 68 119
3.0 37 3.68 NR 140 108 NR 239 NR NR
Normal 1.5 36 3.02 222 206 201 276 276 114 138
3.0 36 2.80 261 209 150 243 295 80 192
Normal 1.5 38 3.55 248 128 116 158 201 35 115
3.0 38 3.50 202 140 84 151 239 66 180
B0: field strength; GA: gestational age; EFW: estimated fetal weight; MPA: main pulmonary artery; AAO: ascending aorta; SVC: superior vena cava; AD: arterial duct;
DAO: descending aorta; PBF: pulmonary blood flow; UV: umbilical vein; RV: right ventricle; LV: left ventricle; NR: Not Recorded due to foetal motion.
Table 2 Inter-observer flow coefficients of variation, by
field strength and vessel type
Coefficient of variation (%)
B0 (T) MPA AAO SVC AD DAO PBF UV
1.5 8 5 16 13 4 34 7
3.0 4 10 11 9 10 11 14
B0: field strength; MPA: main pulmonary artery; AAO: ascending aorta; SVC:
superior vena cava; AD: arterial duct; DAO: descending aorta; PBF: pulmonary
blood flow; UV: umbilical vein.
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data analysis package (MATLAB, MathWorks – Natick,
MA, USA), the individual PC CMR measurements were
reconstructed using MOG. The reconstructed PC CMR
images were exported for flow quantification with regions
of interest drawn around the vessels and flows measured
by two independent observers using the commercially
available cardiovascular post processing software Qflow
(Medis – Leiden, NL). For body mass estimation, foetal
volume was measured from the 3D SSFP data using
Mimics (Materialise Group – Leuven, Belgium). Inter-
and intra-observer reproducibility of flow measurements
at the two field strengths was measured by Pearson correl-
ation coefficient (R2), linear regression and Bland Altman
analysis. Relative differences in flow between the two ob-
servers were also measured for each vessel (i.e., coefficient
of variation). Finally, SNR per pixel was quantified for
each vessel and at each field strength, defined as the vessel
signal intensity (average over the ROI and through time)
divided by the standard deviation of the signal intensity in
uniform maternal fat near the receiver coil.
Results
PC CMR flow measurements were obtained in 36 of 40 tar-
get vessels. In one 3.0 T examination (structurally normal
foetus), persistent foetal motion corrupted data from the
AD, UV and pulmonary arteries. Figure 1a presents a cor-
relation plot from the remaining flow comparisons, showing
strong agreement between corresponding measurements at
each field strength (R2 = 0.78, slope = 0.83 ± 0.16). Figure 1b
is a Bland-Altman plot of the same data, with a mean bias
of -1 ml/min/kg and 95% confidence limits of ±71 ml/min/
kg. All measured flows are provided in Table 1.
Inter-observer agreement was high for flows measured
at 1.5 T (R2 = 0.86, slope = 0.95 ± 0.13, bias = 6 ± 52 ml/min/kg), with similar agreement at 3.0 T (R2 = 0.88,
slope = 0.94 ± 0.13, bias = 4 ± 47 ml/min/kg). The relative
difference in flow measurements between observers, by
vessel and field strength, is provided in Table 2. Differ-
ences were generally low (4–16%), except for PBF which
showed relatively high variability (34%) at 1.5 T versus
that at 3.0 T (11%). This was attributed to the poorly
defined, small pulmonary vessels at 1.5 T, which made
consistent delineation difficult. To demonstrate this, rep-
resentative PC CMR scans from the AAo and RPA of
one subject are shown in Figures 2b and 3b, respectively.
Qualitatively, better vessel depiction and higher SNR
was provided by the 3.0 T scans. However, this difference
in image quality did not translate to dramatic differences
between the AAo flow waveforms (Figure 2c), whereas
RPA flow was less noisy at 3.0 T. Across all measurements,
SNR per pixel at 3.0 T increased by 165 ± 50% relative
to 1.5 T.
Discussion
The potential benefits of CMR as an adjunct to ultra-
sound for foetal assessment are well known, including
improved tissue characterization, lack of a required
acoustic window, and the opportunity to quantify blood
flow and blood oxygen saturation [9]. However, the
Figure 2 Comparison of PC CMR of the AAo at 1.5 T and 3.0 T. (a) Diagram of slice orientation through the foetal anatomy showing major
vascular landmarks. (b) Magnitude and phase (velocity) data at 1.5 and 3.0 T, demonstrating superior SNR and anatomical visualization at 3.0 T. (c)
Corresponding flow waveforms obtained from the AAo at 1.5 T (blue) and 3.0 T (red), and mean SNR (per pixel) for the AAo. RV = right ventricle.
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performed using 1.5 T systems [10], including our own
measurements of flow in foetuses with structurally
normal hearts [5,11] and foetuses with left sided heart
lesions [6]. In recent years, there has been increasing
interest to perform foetal studies at higher field to
shorten acquisition time or to improve spatial resolution.
Victoria et al. recently published their experience im-
aging foetal structures using 1.5 T and 3.0 T systems [7].
Here, we investigated the benefits of higher field strength
for dynamic foetal CMR, specifically foetal blood flow
quantification, and observed SNR gains (165 ± 50%) in
agreement with those reported for gradient-echo im-
aging in adults (160 – 170%) [12]. Because SNR also
depended on many factors beyond field strength, suchFigure 3 Comparison of PC CMR of the RPA at 1.5 T and 3.0 T. (a) Dia
vascular landmarks. (b) Magnitude and phase (velocity) data at 1.5 and 3.0
Corresponding flow waveforms obtained from the RPA at 1.5 T (blue) andas maternal size and foetal position with respect to the
receiver coils, average SNR gain was quoted rather than
per vessel values.
This work provided an opportunity to quantify the re-
producibility of foetal PC CMR between examinations,
with results again comparable to studies previously per-
formed in adults [13,14]. There was no significant differ-
ence in foetal mass values between the two systems.
Similarly, measured flows were not significantly different
between the two systems, and inter-observer agreement
was high. However, flow waveforms in the smaller pul-
monary vessels were more consistent between observers
at 3.0 T, likely as a result of improved visualization of
the smaller vessels provided by the increased SNR at
higher field.gram of slice orientation through the foetal anatomy showing major
T, demonstrating superior SNR and anatomical visualization at 3.0 T. (c)
3.0 T (red), and mean SNR (per pixel) for the RPA. RV = Right ventricle.
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posed its own challenges. First, we were mindful of
the potential increase in acoustic noise levels associated
with a 3.0 T system and the effect it may have on the
mothers. Rapid switching of the magnetic field gradients
is responsible for this acoustic noise, and the permissible
sound level limit is currently set by the US Food and
Drug Administration (FDA) over 140 dB [15]. We
addressed this by providing appropriate ear plugs in
addition to headphones, and subjects did not report
any discernible difference in comfort level between
the field strengths, although this issue was not specific-
ally investigated. Second, energy deposition may be
greater when scanning at higher field. Specific absorp-
tion rate (SAR) is a measure of energy deposition into a
given mass during radiofrequency (RF) excitation. Nu-
merical simulations have demonstrated that foetal SAR
and temperature rise are within safety limits when scan-
ning below < 2 W/kg whole body exposure [15,16]. In
this study, no scans exceeded this recommended SAR.
Finally, with increasing field strength there is an in-
creased sensitivity to spatial signal variation due to sus-
ceptibility artifacts and standing wave phenomena. In
this study, signal variation was most evident but toler-
able at 3.0 T for SSFP imaging.
Limitations of this pilot study are as follows. First,
changes in the physiological state of the foetus (and
mother) between scans were an inevitable confounder.
Second, in one foetus the scans were repeated one week
apart rather than on the same day, which could further
reduce overall agreement; however, this discrepancy was
ameliorated by normalizing flow to foetal mass. Last,
background phase correction was not applied to these
interim results. Despite these limitations, flows obtained
at 1.5 T and 3.0 T were in good agreement.
Conclusion
Foetal flow measurements using PC CMR and MOG
can be obtained at 1.5 T and 3.0 T with high correlation
and negligible global bias. With increased SNR at 3.0 T,
smaller pulmonary vessels were better visualized which
improved inter-observer agreement of associated flows.
This feasibility study is encouraging given the growing
interest in 3.0 T CMR for foetal anatomical and func-
tional cardiac imaging.
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Additional file 1: PC CMR of the fetal main pulmonary artery (MPA)
at 1.5T. Video showing magnitude and phase (velocity) data acquired
from the fetal MPA using PC CMR at 1.5T.
Additional file 2: PC CMR of the fetal main pulmonary artery (MPA)
at 3.0T. Video showing magnitude and phase (velocity) data acquired
from the fetal MPA using PC CMR at 3.0T.Additional file 3: PC CMR of the fetal right pulmonary artery (RPA)
at 1.5T. Video showing magnitude and phase (velocity) data acquired
from the fetal RPA using PC CMR at 1.5T.
Additional file 4: PC CMR of the fetal right pulmonary artery (RPA)
at 3.0T. Video showing magnitude and phase (velocity) data acquired
from the fetal RPA using PC CMR at 3.0T.
Additional file 5: PC CMR of the fetal ascending aorta at 1.5T. Video
showing magnitude and phase (velocity) data acquired from the fetal
ascending aorta (AAO) using PC CMR at 1.5T.
Additional file 6: PC CMR of the fetal ascending aorta at 3.0T. Video
showing magnitude and phase (velocity) data acquired from the fetal
ascending aorta (AAO) using PC CMR at 3.0T.
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